Last reviewed · How we verify
L-697,661
At a glance
| Generic name | L-697,661 |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L-697,661 CI brief — competitive landscape report
- L-697,661 updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI